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INTRODUCTION
Data generated in this laboratory (1,2) utilizing a
renal cortical slice preparation from sodium deficient rats,
suggest that dopamine directly stimulates renin release via
a beta-adrenoreceptor mechanism operating at the level of
the juxtaglomerular cell membrane.

This effect appears to

be coupled with increases in the concentration of cyclic
3' :5 1 -adenosine monophosphate

(c-A}~)

in the renal cortical

tissue, suggesting the participation of this nucleotide as
the intracellular mediator of the stimulatory effect of
dopamine on renin secretion.

Recently (3), we have further

supported this concept by demonstrating that addition of the
phosphodiesterase inhibitor, theophylline, to the kidney
slice system, potentiates the renin release and

c-~~

re-

sponses to exogenous dopamine administration.

Additionally,

tve have proposed (4) that dopamine may inhibit renin release
through a dopamine-specific receptor as opposed to its betaadrenoreceptor mediated stimulatory effect, suggesting a
dual regulatory role for dopamine in the overall regulation
of renin release.

,..i..

2

Intrarenal prostaglandins (PGs) have also been implicated in-the control of renin release (5,6).

la vivo (7,8,

213,214) and in vitro (9,10) observations suggest that exogenous prostaglandin E2 (PGE 2 ) stimulates renin secretion,
but in several instances (11-14) this agent was found to be
ineffective in altering the release of renin.

Alternatively,

prostaglandin F -alpha (PGF 2 -alpha) has been shown to either
2
increase (10) or decrease renin release in vitro (9,13) or
to have no effect in vivo (15).

Renal synthesis of prostaglandins occurs mostly in the
medullary areas (16,17), but some prostaglandins can also be
~reduced

in the renal cortex (18,19).

Renal cortical prosta-

glandin synthesis has been shown to be stimulated by arachionic acid (C20:4) administration (20,21), and to be inhibited
by the effective prostaglandin synthetase blocker, indometha-

cin (22,23,215), as well as by other anti-inflammatory agents
(24 ,25).

Although the mechanism by tvhich intrarenal prosta-

glandins influence renin secretion may be related to their
effects on the renal vasculature (26,27,216), recent in vivo
data have suggested that they rnay affect renin release via a
direct action on the juxtaglomerular cells (28).

3

In vitro renal cortical preparations are particularly
suitable for an effective evaluation of factors which may
directly influence renin secretion.

The release of renin

from the juxtaglomerular cells is influenced by a number of
hemodynamic and humoral factors (29,30) and by the nervous
system (31,32).

An in vitro renal cortical system, by elimi-

nating these influences, thus allows for the examination of
a direct action of prostaglandins and other agents on renin
release.

Furthermore, !g vivo (33,34) and in vitro (1,2,35,36,

37) evidence suggests that dietary sodium deficiency not only
increases resting renin release, but that it also potentiates
the renin secretory rate elicited by sympathoadrenergic discharge.

Recent in vitro studies (38,39,40) have additionally

demonstrated that dietary sodium deficiency also potentiates
the resting concentration and release of intrarenal prostaglandins.

Thus, a renal cortical slice preparation =rom sod-

ium deficient rats

~~hich

maximizes renin release and possibly

intrarenal prostaglandin concentration as

~vell,

is a ·Jiable

model for investigating the nechanism of action by which intrarenal prostaglandins ma:;,r influence renin release.
Therefore, in

vie~v

of the conflicting nature of the data

regarding renal prostaglandin mediation of renin, this study

4
has been designed to (1) determine i f exogenously administered
prostaglandins of the E and F series can directly influence
renin release in a renal cortical slice system from sodium
deficient rats, (2) investigate if blockade of renal alphaand beta-adrenergic receptors modifies the renin secretory
responses to prostaglandin administration, (3) examine if
changes in renal cortical tissue

c-A!~

content in response

to prostaglandin treatment are coupled with those seen in
renin release, and (4) evaluate if administration of indomethacin, an effective prostaglandin synthetase inhibitor,
can influence the

in~reased

resting renin secretory levels

seen in sodium deficient rats.

A positive finding would sup-

?Ort the concept that intrarenal prostaglandins participate
in the regulation of resting renin release in the sodium
deficient state.

LITERATURE
I.

REVIB~

Introduction to the Renin-Angiotensin System. (RAS)
Since the discovery of renin by Tigerstedt (41) numer-

ous studies have clearly implicated the RAS in the regulation
of blood pressure, primarily via the pressor action of Angiotensin II (ANG II) on peripheral blood vessels.

The ANG II

octapeptide is synthesized via the catalytic action of renin.
In turn, renin cleaves angiotensinogen of hepatic origin to
form the decapeptide Angiotensin I (ANG I), the immediate
precursor of Angiotensin II.

ANG I is in turn hydrolyzed by

converting enzyme, present largely in the pulmonary vascular
bed, to ANG II.

Subsequent proteolytic action of circulating
t~e

angiotensinases results in
(A~1G

III), a peptide

~vith

tive metabolites (30).

formation of Angiotensin III

little pressor activity, and inac-

The

&~S

has also

~een

shown to func-

tion in the regulation of blood volume and electrolyte homeostasis.
excretion

ANG II has been demonstrated to influence sodium
throug~

its effect on the renal vasculature <vhich

alters the filtered sodium load and the sum of Starling
forces acting on the pertibular capillaries (42).

Additional-

ly, ANG II infusions stimulate the synthesis and release of
5
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aldosterone and vasopressin

(L~-3,44,217),

importance in renal sodium and
II.

~Jater

which are of primary

reabsorption.

Anatomical Evidence.
TI1e current accepted view places the site of formation,

storage and release of renin in the juxtaglomerular cells
(JG) of the afferent arteriole of the mammalian kidney, although compounds with renin-like activity have been demonstrated in extrarenal regions as well (45,46).

Gra~ular

cells

lining the afferent arteriole wall closest to the glomerulus
•

were first reported by Cberling and Hatt (47) and later confirmed by other investigators (48,49,218,219,220), and sodium
deficiency has been shown to increase the

nQ~ber

and granula-

tion of rat JG cells (53,37).
III.

Regulato~y

Mechanisms Involved in the Control of Renin

Secretion.

A.

The Hacula Densa Receptor.
Substantial evidence suggests the existence of
a functional relationship

bet~veen

the macula densa

and the granular cells involved in renin secretion.
Hovlever, the exact nature of the signal detected by
the cells of the macula densa and the mechanism DY
1

~vhich

the signal is detected and transmitted i:o the

7

renin-secreting cells is still open to question.
Barajas (43), based on electron micrographs of rat
JG cells, has suggested that decreased contact between these cells and the macula densa cells of the
distal tubule would result in increased renin secretion.

This decreased stretch of the tubular cells

has been attributed to a lowered sodium load in the
distal tubule with an accompanying volume reduction,
thus resulting in decreased contact.
Hicro;_Juncture experiments (50) point to an inverse relationship between renin release and total
sodium load delivered to the macula densa.

This in-

verse relationship has been confirmed by Nash et al.
(51) \vho demonstrated in dogs the dissociation of

renin release from renal hemodynamics and water and
sodium balance, but not from the filtered load of
sodium.

They suggested the existence of an intra-

renal, e:{travascular sodium-sensitive mechanism,
which responds directly to changes in sodium flux
across the macula densa.
rat

~ddney

Recent '>1ork in the isolated

has lent support to this concept (52).

Hm-vever, studies utilizing ret:::ograde injections of

8

high sodium buffer into the distal tubule have sugg~sted

instead a direct relationship between fil-

tered sodium load and renin release (53,221).
B.

The R?nal Baroreceptor.
Embryonically, JG cells are derived from stem
~vhich

cells

~ave

they

normally form smooth muscle (54), although

developed the ability to functionally behave

as endocrine cells, which the remainin6 smootZ: muscle
cells of t2e afferent
2.2 tte:::,

~;.mvever,

do not have.

T2e

can indirectly affect JG cell func-

tion by responding to
~alls.

arte~iole

T~erefore,

c~~~ges

t~e

i~

existe~ce

the stretch of their
cf a

re~al

vascular

rece?tor, sensitive to stretch and thus to alterations
in renal ?erfusion pressure has been

investi~ated.

In der:erva ted-, adrenalectomized-, :.on- fil terin6 canine

~ddneys,

i~cr2ase

renin secretion has been observed to

in response to

decre~sed

renal

~erfusion

pressure associated tvith hemorrl1a.r2:e and 5raded su?rarenal aortic constriction (55,56,57,222).
creased renin

secreto~y

This in-

response was no longer appar-

ent "i.1en oerfusion pressures 'vere restored to normal
1

..L.eve.Ls.
~

?u:::therrnore, in vi-;o administration of the
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smooth muscle relaxant papaverine has been demonstrated
to abolish the renin secretory responses to hemorrhage
in canine-denervated-, non-filtering kidneys (58),
although it is possible that this effect may have been
due to a direct effect of papaverine on the JG cells.
Recent in vitro experiments utilizing a rat renal
cortical cell suspension have shown papaverine may
directly inhibit renin secretion (59).
C.

The Nervous System.
1.

Central Nervous System Regulation of Renin Release.
The possibility of a brain renin-angiotensin
system participating in the central

re~ulation

of

perip'::eral blood pressure has long been debated.
T.'lere is generalized agreement t'.1at circulating
AFG II or ANG III influence some brain regions
located outside

t~e

blood-brain barrier (60).

Several components of

t~1.e

strated intracerebrally as

RAS .-:ave been demon1

(51).

~ell

}~wever,

the issue of whether it is renin or an isorenin
\-7l-:dch is 1?resent intracerebrally remains unreso 1 ved.
Endo3enous brain renin and

t~e

renin-like enzyme,

Cathepsin D, co-?urify by gel filtration and ammonium sul;?bate fractionation (62);

Cat~l.epsin

D, as

10

does renin, will react :vith renin subs t:ra te to
form ANG I (63), although the activity of this
so-called "brain-renin 11 decreases abo\re pH 7.0,
Nhile the optimal pH for renal renin activity is
at 7.4 (64).

Recent investigations have demon-

strated a fraction of Cathepsin D which has reninlike optional activity at pH 7.4 and is effectively neutralized by anti-renin anti-sera (65,66,67,
223,224,225).
a.

T~e

Effect of Plasma

Angiot~~sin

on the Brain.

Confirmation cf plasma angiotensin influence on the brain

~vas

provided in an ele-

gant experiment by Bickert:on et al. (68).

In

this cross-perfusion study, the head of a
recipient dog, isolated from its circulation
but connected to its sninal cord, was perfused
tvith blood from a donor dog receiving ANG II
injected into its circulation.

Peripheral

arterial pressure tvas observed to increase in
the recipient dog ;.vhile ANG II \vas infused
into the donor.
Nediation of plasma ANG II influence
on the CNS must occur outside the blood-brain

11

barrier, since this

pe~tide

blood-brain barrier (69).

cannot cross the
The pressor re-

sponse to ANG II infusions into the vertebral
artery of dogs has been shown to occur only
if the circulation to the area postrema, outside the blood-brain barrier, remains unimpaired (70).

Moreover, injections of ANG II

into the vertebral artery inhibit reflex vasodilation in

t~e

dog (70), suggesting a possi-

ble role for ANG II in modifying the inhibitory activity exerted bv vasomotor effector
neurons (70).

Neural connections have also

been demonstrated between the area postrema
and the nucleus of the tractus solitarius
(70) which receives input from the glossopharyngeal and carotoid sinus nerves and in
turn operate as a relav for afferent baroreceptor impulse integration (71).
Direct administration of ANG II into
the cerebral ventricles causes increased
secretion of both vasooressin and ACTR and
a rise in blood pressure (44,72).

These

12

responses have been mimicked by intraventricular injection of purified renin (73), and
responses to both peptides are abolished by
the competitive ANG II antagonist, Saralsin
(73).

Additionally, converting enzyme inhib-

itors have been shown to block the response
to intracerebral injection of renin (73),
thus further supporting the view that the
observed responses are due to ANG II of
cerebral, rather than peripheral origin.
b.

Central Influence on Renal Renin Release.
The postulation that the CNS plays a
role in modulating renal renin release has
been arrived at as a result of the following
observations:

(1) Cathepsin D, an enzvme

a?parently containing a renin-lU\.e component,
activates inactive renin in human amniotic
fluid (74).
~vith

This observation taken together

the intracerebral demonstration of

Cathe?sin D suggests a possible central
?hvsiological role for

t~is

enzyme; (2) cen-

tral mediation of peripheral activation of
inactive renin has been

s~own

(75); (3) in

13
~

pharmacological evidence indicates that

stimulation of central serotoninergic pathways increases peripheral renin release (76);
(4) stimulation of the posterior hypothalamus,
medulla oblongata, and pons, increases renin
secretion and is associated with a rise in
blood pressure; and (5) renal denervation
abolishes the increase in renin release in
response to central stimulation (73).
Clonidine, a known central alphareceptor agonist agent, has several actions
on the brain.

It decreases plasma ACTI1

through an action on the hypothalamus, and
injections of this agent into the blood
perfusing the medulla and the pons result
in a significant depressor response (73).
Furthermore, vertebral or carotoid arterial
administration of clonidine produces a decrease in plasma renin activity (73).

Bi-

lateral lesions of the canine ventral medulla abolish the decreased splanchnic nerve
discharge associated with clonidine injection, while the depressor response remains

14

intact.

Thus, these data point to a separate

site for the renin-lowering effect and the
depressor responses to this agent (73).
Injections of clonidine into the cisterna magna of anesthetized, bilaterally
splanchnictomized dogs, do not result in decreased plasma renin activity, whereas the
same dose injected into animals with intact
splanchnic nerves result in a significant
•

decrease in hemorrhage-stimulated increases
in plasma renin activity.

These data suggest

that clonidine reduces sympatheticallystimulated renin via a central mechanism dependent on splanchnic nerve integrity (77).
The renin-lowering effect of clonidine may be
exerted through an excitatory action on intracerebral alpha-adrenoreceptors (73).

Clonidine

has been shmvn to have a greater affinity for
pre- rather than post-junctional alphaadrenoreceptors (78).

Hor:Jever, the evidence

regarding the action of clonidine on renin
release is not yet complete.

Clonidine ap-

?ears to decrease sympathetic discharge rate

15
even when pre-synaptic inhibition is abolished
by reserpine-induced catecholamine depletion
(79).

Additionally, a neurally-mediated

decrease in renin secretion, which can be
abolished bv renal denervation, has also been
reported when L-dopa is administered with carbidopa to provoke catecholamine release (80).
Furthermore, while injections of norepinephrine, epinephrine and dopamine into the third
ventricle of the dog increase renin secretion,
injections of clonidine into the same site
decrease renin secretion (73).

~1us,

these

data indicate that agents with high affinities for post-synaptic receptors increase
renin secretion while agents with high affinities for pre-synaptic receptors decrease
renin secretion.
2.

Peripheral Nervous System Regulation of Renin
Release.
a.

Anatomical and Functional Evidence.
A large body of evidence suggests that
the sympathetic nervous system innervates the
JG cells and thus can directly modulate renin

16
release.

Electron microscopic studies (81-83)

have clearly shown this extensive sympathetic
innervation of the renin-secreting cells, and
fluorescent histochemical studies and chemical
assays (84,85) have further supported this
view.

Furthermore, circulating catecholamines

of adrenal medullary origin can directly influence renin release by acting on renal
adrenergic receptors, in addition to their
indirect effects exerted through the renal
baroreceptors and macula densa receptors
(29-32).
Functional evidence for a direct sympathetic effect on renin secretion, independent
of hemodynamic and macula densa influences,
has been provided by numerous studies.

In

papaverine-treated dogs with non-filtering
kidneys, electrical stimulation of the renal
nerves increases renin release (86).

Similar-

ly, in vitro administration of catecholamines
stimulates renin secretion (1,2,35,36,87,88,
96,98), presumably by a direct action on the
JG cells.
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b.

The Renal Beta-AdrenerAic Receptor.

-

Abundant in vivo and in vitro data have

--

firmly established the concept that circulating catecholamines and norephinephrine released by renal nerve terminals, can directly stimulate renin release (1,2,89-93).

This

direct stimulatory effect appears to be exerted via a JG cell membrane-bound beta-adrenoreceptor mechanism (36,90,94,96,100-102,104,
226), since blockade of this receptor mechanism
by specific pharmacological agents such as
propranolol and pindolol effectively prevents
the increase in renin release seen in response
to sympathetic stimulation (31,36,90,92,9L:--97,
100-104,227,228).
Tiie stimulatory action of beta-adrenoreceptor activation on renin secretion has
been suggested to be coupled

~·Jith

a simultane-

ous increase in the levels of cyclic 3!5'adenosine m.onophosphate (c-Ar'IP) in renal tissue (1,2,36)

\v~1ich

mav indicate that this

nucleotide acts as the intracellular mediator
of sympatl1etic stimulati.::>n of ::enin r2lease

18
This

(229).

vie~;·J

has been further supported

by the demonstration
ase inhibitor,

t~1at

the phosphodiester-

t~eophylline,

potentiates the

stimulatory action of catecholamines en renin
release (98,99,105,107).

Additionally, admin-

istration of dibutyryl c-AHP to isolated rat
renal cortical tissue increases renin release
in a dose-dependent fashion (108), an observation tvhich has been confirmed in other in vivo
and in ''i tro studies ( 90, 106, 109) .
The type of

beta-a~renoreceptor

specif-

ically involved in the regulation of renin
r2l·~ase
~;_2cent

has not yet been fully determined.
data suggest t:l.e involvement of a beta 1 -

adrenoreceptor

rat~er

than a beta 2 -type similar

to tte one present in cardiac tissue (110-112,
230), but some in vitro studies indicate that

the renal beta-adrenoreceptor may nc·t belong
to either ty?e (113).

Furthermore, Saruta et

al. (114), have suggested that the decrease in
renin release associated with beta-adrenergic
blockade is due to a membrane

stabilizi:::~

19
effect of the blocking agents rather than to
their functional beta-blocking actions.
c.

The Renal Alpha-Adrenergic Rece2tor.
Stimulation of intrarenal alpha-adrenoreceptors has been shown to result in an
inhibition of renin release (100,115-117).
Furthermore, a1pha-adrenoreceptor antagonists
have been demonstrated to abolish the inhibit~ry

effect of a1pha-adrenoreceptor activa-

tion of renin release (36,93,98,100,118).
Taken together, these-observations suggest an
inhibitory role for intrarenal alpha-adrenoreceptors in the regulation of renin release.
d.

The Renal Dooamine Receptor.
Dopamine has been shown to be present
in canine renal tissue (118).

The renal vase-

dilating prooerties of this amine have been
postulated to indirectly influence renin release (120,121,122), and

t~ese

renal vascular

effects apparently involve .;m interaction t.Jith
dopamine-specific receptors located on
renal vascular walls (123,124,125).

t~e

20
Dopamine has also been found to increase
the c-N1P content of rat renal oarticulate
preparations (126,127) which suggest that the
renal vascular actions of this amine mav be
mediated by adenvlate cvclase svstems functionallv coupled with renal vascular dopaminergic receptors.
served changes

i~

Alternatively, the ob-

renal tissue c-AJ1P content

in response to dopamine administration may reflect an action of this agent on cells other
than vascular cells, such as the JG cells,
suggesting adenylate cvclase mediation of a
direct effect of dopamine on renin release
(128,129).

This possibilitv has now been

suggested bv in vitro studies (1-3,130,131),
in

~.vhich

dopamine administration simultc:neous-

lv stimulated

bot~

renin release and tissue

c-AMP content in rat renal cortical tissue.
Furt:1ermore, this effect

~vas

shmvn to be

effectively blocked bv propranolol in these
studies, suggesting

t~at

mediation of the

stimulatorv action of dooamine on renin
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secretion is via a beta-adrenoreceptor mechanism.
Converselv, administration of dopamine-receptor
blockers such as haloperidol (f3l) and d-butaclamol
(4) has been demonstrated to potentiate the stimulation of renin release bv dopamine, tvhich may
indicate that renal dopaminergic receptors may regulate renin release in an inhibitory fashion.

The

physiological significance of this dual regulation
is unclear, but a similar dual type of control has
•
been proposed to exist in regard to the action of

norepinephrine on renin release (36,115,117,118).
3.

Humoral Influences in the Control of Renin Release.
a.

Angiotensin II (ANG II).
Peripheral infusions of ANG II have been
shmvn to inhibit renin secretion (42).

In sod-

ium deficient sheep (132), chronic ANG II administration prevented the expected rise in
plasma renin activity, seen in the sodium deficient state.

ANG II has also been reported to

inhibit renin

secre~ion

in the absence of a

functional renal baroreceptor or macula densa
(133), suggesting a direct inhibitory action
of ANG II on the JG cells.

Furthermore, Keeton

22
et al. (134) have suAgested that infusions of
saralasin, an ANG II competitive inhibitor,
disrupts the ANG II short-loop, local inhibitory feedback mechanism on renin release,
which is also associated with the intrarenal
beta-adrenoreceptors, and in vitro observations by Ganong and Lopez (36) have demonstrated that ANG II administration inhibits the
stimulatory effect of norepinephrine on renin
secretion, and that this effect is coupled
with corresponding decreases in the c-AMP content of the renal cortical tissue.

Thus, it

appears that in addition to its indirect actions in the regulation of renin release,
namely, via its central and peripheral vascular effects, ANG II has the abilitv to locally
control the secretion on renin by a direct
s~:ort-loop

feedback mechanism operating at the

JG cell level.

However, a negative feedback

effect exerted by ANG II on the JG cells was
not observed in a recent in vivo investigation
by Baer and her associates (135).
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b.

Vasopressin (ADH).
Some investigators have also reported
that ANG II infusions increase the plasma
concentration of vasopressin (44,136,137).
Since it has also been shown that vasopressin inhibits renin release (44,137,138), it
may be possible that the inhibitory regulation of renin release by vasopressin may be
the result of ANG II-mediated central stimulation of vasopressin release, although the
actual mechanism by which vasopressin influences renin secretion remains unclear.

c..

Electrolytes.
In addition to sodium, other electrolytes
also appear to regulate renin secretion.

Chlo-

rine has recently been reported to increase
renin release in rats independent of sodium
concentration (139).

In experiments \•Jith de-

nervated, auto-transplanted canine kidneys, hypermagnesia has been demonstrated to stimulate renin release independent of hemodynamic,
nervous and natriuretic factors (140).

The

mechanism of action involved in this effect
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appears to be related to the antagonism which
exists between magnesium and calcium in controlling renin release.

Recent _...;..,;;...;;.,;;..;;.
in vitro work

(141) has demonstrated that potassium-free
media causes a depression of renin release in
renal cortical tissue, and that this effect
is partially prevented when calcium is also
absent from the media.

Vandongen and Peart

(142) have also demonstrated that ANG II will
not inhibit basal renin secretion in the
absence of calcium.

These observations point

to a regulatory influence of calcium on a JG
cell membrane response to ionic influences
(231,232).
4.

Regulation of Renin Secretion by Intrarenal Prostaglandins.
Synthesis of prostaglandins (PG) has been demonstrated to occur in a variety of peripheral vascular beds (143,144).

In the kidney, the concentra-

tion of PG synthetase is highest in the medulla
and papillae but there is also significant PG
production in the renal cortex (17-20,145-147).
Renal cortical synthesis of prostaglandins is
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dependent on the conversion of free arachidonic
acid (C20:4) to the endoperoxide PGG 2 via the
action of cyclooxygenases.

Subsequent reductase

activity results in the biosynthesis of PGE 2 or
PGF -alpha while isomerases catalyze the conver2
sion of PGG

or PGF . Additionally, PGE may be
2
2
2
converted to PFG -alpha via the action of PGE 92
ketoreductases (148). Although it is generally
accepted that renal prostaglandins play a predominant role in the control of renal vascular
dynamics (25,26,144), their presence in the renal
cortex has led to numerous studies designed to
investigate the possibility of a regulatory influence of these agents on renin secretion (5,6,
149-155), either directlv or indirectly.
a.

Indirect Regulation of Renin Secretion by
Prostaglandins.
i.

PG Involvement in the Macula Densa and
Baroreceptor Control Hechanisms.
Prostaglandins appear to be required for effective macula densa function.
In unilaterally renal denervated-, contralaterally nephrectomized-, papaverine- and
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propranolol-treated anesthetized dogs, the
PG synthetase inhibitor indomethacin, has
been shown to abolish aortic clampstimulated increases in plasma renin activity (156).

Additionally,

indomethacin

can inhibit the increased plasma renin
activity associated with decreased early
distal tubular sodium load in both sodiumreplete and deficient rats (157).
Studies utilizing adrenalectomized-,
renal denervated-, propranolol-treated,
non-filtering canine kidneys 111ith contralateral nephrectomy, have suggested a role
for cortical PGs in the intrarenal baroreceptor control of renin release (158).
In this study, indomethacin abolished the
rise in plasma renin activity associated
with decreased renal perfusion pressure
and intrarenal infusion of C20:4.

This

suggests that cortical, rather than medullary PGs are involved in

t~.e

intrarenal

baroreceptor response, since medullary
cyclooxy~enase

products cannot be

27

transported to the cortex via

t~bular

fluid in treated anesthetized do;s,
PG synthetase

inhi~itor

t~e

indomethacin, has

been shmvn to abolish aortic clampstimulated increases in plasma renin
activity (156).

Additionally, indometha-

cin can inhibit the increased plasma
renin activity associated with decreased
early distal tubular sodium load in both
sodium-replete and deficient rats (157).
Studies utilizing adrenalectomized-,
renal denervated-, pro?ranolol-t;:eated,
non-filtering canine kidneys

~vith

contra-

l2teral nephrectomy, have suggested a
role for cortical PGs in the intrarenal
baroreceptor control of renin release
(158).

In

t~is

study, indomethacin abol-

ished the rise in plasma renin activity
associated

~vith

decreased renal ryerfusion

pressure and intrarenal infusion of C20:4.
This suggests that cortical, rather than
medullary PGs are involved in the intrarenal baroreceptor response, since medullary
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cyclooxvgenase products cannot be transported to the cortex via tubular fluid in
the non-filtering kidney (158).

These

observations have been recently extended
by the demonstration that PGE 2 and PGI 2
of cortical origin are necessary for baroreceptor stimulated renin release (159).
Thus, current evidence suggests the involvement of medullary and cortical PGs
in t'tvo of the three major mechanisms which
regulate renin release.
ii.

The Relationship Between PGs and Angiotensin II (ANG II).
In vivo evidence has indicated endogenous renal PG mediation of the ANG II
short-loop feedback mechanism.

Adminis-

tration of tt..,e ANG I converting enzyme
inhibitor, SQ 14225, results in a

si~nifi

cant increase in ?lasma renin activity
~·1::-:.ich

is abolished following indomethacin

infusion (160).

Indomet~1acin

has also

been shm·m to decrease ANG IT-induced
aldosterone release in sodium deficient
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rats (161).

Alternatively, experiments in

the isolated rat kidney suggest that ANG
II increases PGE

2

biosynthesis (162), and

the production of an increased renal venous
PGE-like agent associated tvith lortJ frequency
renal nerve stimulation, has also been reported to be mediated by ANG II (163).
iii.

PGs and the Renal Nerves.
vrr~ile

experimental evidence suggests

a role for PGs in modulating sympathetically-evoked renin release, the mechanism
involved in this action has not yet been
determined (164,165).

In renal-denervated

dogs, treated with cvclooxygenase inhibitors while undergoing hemorrhage, plasma
renin activity remained unaltered in relation to control levels (166).

However,

direct stimulation of the renal sympathetic
nerves in anesthetized dogs has been

sho~·m

to simultaneously increase renin release
and PGE 2 levels t\vo-£old over those of
control (167).

Furt~ermore,

isoproternol-

stimulated renin release in rats is reduced
by 67% following administration of

J
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indomethacin, while this same agent attenuated the rise in serum renin levels caused
by the beta 1 -adrenoreceptor agonist Hl33/22
by 80% (168).

Catecholamine infusions have

also been reported to increase PG release
in the isolated, perfused rabbit kidney,
thus suggesting a role for the renal
nerves in stimulating PG synthesis (169).
These observa.tions taken together, support
the existence of a mechanism whereby sympathetic stimulation, which may be under the
tonic restraint of cardiovascular reflexes,
evokes simultaneous increases in renin release and PG biosynthesis, with PGs acting at a site distal to ths intrarenal
beta-adrenergic receptor.
iv.

PG Synthetase Inhibitors and Their Relation
to the RAS.
In an attempt to clarify the mechanism
bv '.vhich intrarenal PGs may influence renin

release, the non-selective,

cyclooxy~enase

inhibitor, indomethacin, has been utilized
in a number of investigations.

Indomethacin,
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in doses of 5-10 mg/kg, has been reported
to significantly decrease resting (basal)
plasma renin activity in rabbits and dogs

(19,20,233).

Similar doses have also been

reported to lower the level of immunoreactive renal venous PGE substances, as well
as to decrease plasma renin activity in
normal and hypertensive rabbits (22,24,25,

170).

Studies in normal and hypertensive

man have generally supported these observation~

(171-173,234).

Indomethacin can also suppress the
rise in the levels of active renin associated with furosemide administration

(174) and to decrease those of inactive
renin and acid-activated renin in man,
which suggests that PGs may mediate the
conversion of inactive to active renin

(175).
ies

Additionally, recent in vivo stud-

~1ave

confirmed

t~1ese

observations and

have further suggested a definite role
for newly

synt~esized

PGs in regulating

r2nin release via a direct action on the
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JG cells (19,20,177,178).
Recent

1a Y!Y£

investigations util-

lizing non-filtering-, denervated-, papaverine-treated canine kidneys, support the
concept of a direct action by PGs on the
JG cells to mediate renin release (28).
In these studies, 60-min infusions of
C20: 4 (15

ug/l~g/min)

produced significant

increases in both renin release and PG
levels.

On the basis of these results

it appears likely that the C20:4- evoked
increases in renin release are due to a
prior conversion of C20:4 to prostaglandins which then influence the JG
cells, independent of other regulatorv
mechanisms.
ii.

Effect of PGE 2 .
In vivo and in vitro evidence suggest that PGE

2

either increases or does

not alter renin release under a variety
of experimental manipulations.

Utilizing

a rabbit renal cortical cell preparation,
-12
PGE 2 at various concer-.trations (3xl0
H,

1 ~,,i
,," .

\

''

/
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-, 0
-7
3xl0 ... M, 3xl0 H) has been shown to in-

crease renin release ':vith maximal stimulation produced by the
of PGE

2

used (9).

lo~-Jest

concentration

In another study (10),

a dose of 2.0 ug/ml of PGE

caused a grad2
ual increase in renin release over sixty

minutes of incubation, and PGE doses from
2
-6
-4
3xl0 M to 3x10 M have recently been
shmvn to increase in vitro renin release
in a dose~dependent manner in rats (179).
Furthermore, in isolated rat glomeruli,
administration of 5 ug/ml of C20:4 produced a tenfold increase in PGEz and a
twofold increase in renin release (180).
In the isolated, perfused rat kidney,
thirty minute infusions of 5, 10 or 50
ng/ml of PGE

have been reported to pro2
duce significant dose-dependent increases
in renin release (181).

Similarly, in the

anesthetized dog, 10-min. infusions of
14-60 ng/kg/min of PGE

resulted in dose2
dependent increases in both renin release

and renal blood flmv ( 7), \A7hile
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administration of acetylcholine, bradykinin,
and the depressor agent eledoisin only increased renal blood flmv without affecting
renin release, thus suggesting a direct
action of PGE 2 on the JG cells to influence
renin release (7).

Yun and his associates

have also reported increases in renin release in sodium deficient dogs with nonfiltering kidneys, follmving 60-min infusions of PGE 2 (4.12 ug/min and 1.03 ug/min),
fur~her

supporting the concept of a direct

role for PGs in modulating renin release
(15,182).

Additionally, chronic intra-

renal infusion of 2 ug/min of PGE

over
2
7-8 days in unilaterally-nephrectomized,

conscious dogs, resulted in eight-fold
increases in plasma renin activity tvhich

~:.vas

attenuated following SQ 14225 administration
on day 9 (183,184).

Thus, taken to;sether,

these data support the view of a direct action of PGE

on the renin-secreting cells
2
to influence renin release, although the
mechanism involved in this action remains
unclear.
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In contrast, 10

-6

M PGE

reported to be ineffective

2

i~

has been
altering

renin release in rabbit renal cortical
slice preparations (13,14,185).
ly, intrarenal infusions of PGE

Similar2

(0.1-5.0

ug/min) for sixty minutes in renaldenervated, anesthetized dogs have also
failed to elicit significant increases
in plasma renin activity (11), and 30 min
infusions of 10-5000 ng/min of PGE

have
2
also been reported to have no effect on
plasma renin activity in anesthetized dogs
(12).

Therefore, at present the possibil-

ity of a stimulating influence of this
prostaglandin on renin secretion requires
further evaluation, in view of the conflicting nature of the data currently
available.
iii.

Effect of

PGF~-alpha.

Data pertaining to a possible influence of PGF -alpha on renin secretion
2
are also conflicting. 1£ vitro studies
using rabbit renal cortical cell preparations (9), have shown that PGF 2 -alpha at
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-12
-9
various doses (3xl0
H, 3xl0 M and
-7
3xl0 M) significantly decreases renin
release. Furthermore, the addition of
-12
-6
10
H to 10 ~1 of PGF -alpha to rabbit
2
renal cortical preparations have also resulted in significant decreases in renin
release in a dose-dependent fashion (13,
14).

Conversely, recent studies (10),

utilizing similar renal cortical systems
have demonstrated that 0.2 ug/ml PGF 2
alpha stimulates renin release when the
prostaglandin was prepared in albumincontaining physiological buffer, while
the same dose inhibits basal renin release

~vhen

the vehi_cle tvas ethanol (10).

Alternatively, unilateral, intrarenal
infusions of 1.03 ug/min of PGF -alpha
2
for 1.5 hours had no demonstrable effect
on renin release in intact canine kidneys
(15).
iv.

Effect of PG Endoperoxides.
Current evidence indicates that the
PG-synthetase intermediates, the
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endoperoxides, are capable of stimulating
renin release in vivo and in vitro.

For

instance, in vivo unilateral infusion of
a synthetic PG-endoperoxide analogue, EPA,
significantly increases renin release and
this effect is prevented by prior treatment with indomethacine (186), although
the rise in renin release in response to
EPA administration appears to be the result of prior conversion of EPA to PGE
(186).

2
In vitro studies (13,14) utiliz-

ing a rabbit renal cortical preparation
have also shown that the synthetic endoperoxide analogues EPA I and EPA II and
the naturally occurring endoperoxide,
PGG , can significantly stimulate renin
2
release to a similar extent (60% over control levels).

Since in these studies PGE

2

was without effect and PGF -alpha actually
2
decreased renin secretion, it appears that
the PG endoperoxides themselves are responsible for the observed rise in renin
secretion.
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v.

PG-elicited Stimulation of Cyclic AMP.
It is generally accepted that intrarenal PGs stimulate renal tissue cyclic

A11P levels, but whether this is a nonselective effect of PGs on intrarenal
adenylate cyclase systems or a specific
action on JG cell membrane adenylate cyclase complexes, is not clear.

In iso-

lated rat glomeruli, adenylate cyclase
stimulation, has been shown to occur following administration of 2xl0

-5

M PGE 2 ,

while equimolar concentrations of PGF 2
alpha were ineffective (187). Also, higher concentrations of PGE and PGF 2 -alpha
2
-4
(8xl0 M) have resulted in a significant
stimulation of cyclic AI>1P content of rat
renal cortical slice tissue (188).

Con-

versely, a 10-fold decrease in the concentration of PGF -alpha resulted in the loss
2
of the stimulatory action of this agent on
renal cortical cyclic

A~P

content.

Simi-

lar results have been reported in experiments utilizing both renal medullary and
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cortical slice tissue (189,190).

Unfor-

tunately, renin release changes were not
simultaneously evaluated in any of these
studies.

Recently, unilateral, intra-

renal infusion of dibutyryl cyclic AMP
into the renal artery of anesthetized
dogs, has been shown to significantly
stimulate renin secretion even in the
presence of indomethacin, suggesting that
PG-synthetase activity does not play a
role in cyclic A}W-mediated renin release
(191).

Indomethacin has also been re-

ported to be ineffective in altering theophylline-induced increases in plasma renin
activity in rabbits (192), while theophylline has been shown to directly stimulate
PG-synthetase in rabbit renal microsomes
(193).

Taken together, these results sug-

gest that the stimulatory effect of PGs on
renal adenylate cyclase systems may be confined to vascular and tubular cells different from the JG cells.
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vi.

PGs and Their Relationship to the JG Cell
Beta-adrenergic Receptor.
Independent observations that intrarenal PGs are capable of stimulating renin
release as well as renal tissue cyclic

Al~

content, pose the attractive possibility
that the effect of PGs on renin secretion
may be mediated by a membrane receptor
mechanism which utilizes cyclic AMP as the
intracellular second messenger, similar to
the beta-adrenergic receptor mechanism
which modulates the stimulatory effect of
catecholamines on renin release via mediation by cyclic A}W content changes (1-4,35,
36).

This possibility is supported by in

vivo studies (194-196,235), showing that
..............
indomethacin administration can suppress
the anti-hypertensive effect of betaadrenoreceptor blockade in man, cats and
rabbits.

However, in isolated rat glomer-

uli (197), beta-adrenoreceptor blockade
has failed to inhibit the increased release of renin seen in response to C20:4
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infusions, thus suggesting that PGs stimulate renin release independently of a betaadrenoreceptor mechanism.
vivo
............

Furthermore,

!a

studies have demonstrated the failure

of indomethacin to prevent the rise in
plasma renin activity produced by norepinephrine and isoproterenol infusions in
the dog (198).

Recent studies utilizing

superfused rat renal cortical slices (179),
have shown that PGE -induced renin release
2
cannot be blocked by doses of propranolol
which normally abolish isoproternolstimulated renin release.

Thus, the bulk

of the evidence suggests that while cyclic
AMP may perhaps mediate PG-elicited renin
release, the mechanism involved in this
action may not be of the beta-adrenoreceptor type and that the systems may function
independently of each other in regulating
renin secretion.

MATERIALS AND METHODS

Twelve male, Sprague-Dawley rats (Sprague•Dawley Co.)
were fed a sodium deficient diet (Teklad Test Diet Co.) providing less than 0.02 mEq. of sodium per day for 2.5 to 3.5
weeks and had free access to distilled, deionized water.

The

rats were kept in a temperature- and light-controlled room
0

(23+2 C; 12 hours light and 12 hours dark), Nith two animals

-

per cage.

At the end of their dietary intake period the

animals were sacrified by decapitation, their kidneys placed
in Robinson's buffer medium at

4°c

(199), and subsequently

gassed for 30 sec. with a mixture of 95%
and after decapsulation.

o2 -5% co 2

prior to

Slices of renal cortex (approximate-

ly 0.3 mm thick) were prepared using a Stadie-Riggs microtome
(A. Thomas Co.).

Each cortical slice was further divided in-

to several similarly-sized portions (according to the number
of treatments) and then randomly assigned to separate incubation vessels containing 2.5 ml of

~obinson's

0

buffer at 4 C.

This procedure Nas repeated using slices from other cortical
areas until each vessel contained
(wet weight).

The random

50~30

distri~ution

mg of cortical tissue

of the sliced tissue

insured t:hat all i.ncuba tion beakers contained
42

relati~rely

43

homogenous cell populations from each cortical area.

One ves-

sel froai each group Nas utilized as a common, non-treated control.

The renal cortical tissue

~vas

then preincubated for 15

min at 37°C in a shaking Dubnoff ~1etabolic Incubator (Precision Scientific Co.) in an atmosphere saturated with 95%
- 5% co • The preincubated slices were subsequently trans·
2
2
ferred to new incubation vessels containing 2.5 m1 of fresh

0

Robinson's buffer and incubated for 60 min under 95%

co 2

o2

- 5%

0

at 37 C.
•

Groups of beakers having a common, unstimulated control

-5

sample, were treated with either prostaglandin E (PGE ; 10 M)
2
2
5
or prostaglandin F,-alpha (PGF -alpha; 10- M) added se?arate2
lt
ly or together with the beta-adrenergic receptor blocker propranolol (10

'
-...;.

M), or the al?ha-adrenergic receptor blocker

phentolamine (10
T.~e

as

-I.!.

~·1)

to the renal cortical slice preparation.

prostaglandin synthetase inhibitor, indomethacin (10
~vell

-4

M),

as orooranolol
and ohentolarnine
tvere also added alone
.
.
.

tc the kidney slice system.
and PGF -alpha solutions were pre2
2
pared in absolute ethanol to t~e d~~ired concentrations. Pro~~domethacin,

PGE

pranolol (Sigma) r.vas dissolves in 0.1% ascorbic acid, \vhereas
phentolamine (CIBA) solutions

~vere

made in sterile r.vater.

The
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alpha- and beta-receptor blocking agents as well as indomethacin were added to the tissue preparation before
incubation and incubation periods.

~oth

the pre-

In turn, the prostaglan-

dins were added before the 60 min incubation period only.
Following incubation, the supernatant medium ~-~as colo
lec~ed and stored at -20 C before ~eing measured for renin
concentration by radioimmunoassay of angiotensin I (200).
The incubated tissue used for cyclic AHP content determination was immediately frozen on dry ice, homogenized in 8%

tr~chloracetic acid, and stored at -20°C, until assayed by
a rnodificc:.tion of the com-petit:i,,e protein-binding assay of
Gilman (201).
Ex-:raction and measurement of tissue cyclic Atv.!P 'i7ere
accomplished by thatving the ?reviously frozen tissue hcmo3enatas in an ice-cold water bath folletved by centrifugation
0

at 4000 rpm for 15 min at 4 C.

Tl"le supernatant 'vas t'.1en

t-:::-2-nsferred to conical centrifuge tubes while the precipitat.;;d.

?rote in

~vas

discarded.

'·iashed four ti:nes

~vith

The samples were subsequently

2.0 ml each of \vater-saturated ether,

and the ether chase discarded.

After the final wash, the

c:;clic Al·.!P-containing Nater :J::ase r.vas decanted into glass
6laced on dry ice for

ra~ii

,.

.

:creez~n5.

The frozen
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samples

~·1ere

t!.l.en lyophyilized and the freeze-dried residue

was stored at -20°C prior to the measurement of cyclic ~~~
content.
Al1P per

~e

mg

values were expressed as picomoles of cyclic-

of wet tissue.

Renin concentration in the supernatant samples was
indirectly measured by determining the rate of angiotensin I
generation following exposure of endogenous renin present in
the collected medium, to exogenous renin substrate (angiotensinogen) obtained from 6 hr nepnrectomized dog plasma, during
0

a t:vo-hour incubation period at 37 C.

Angiotensinase-and

converting enzyme inhibitors \-7ere added to the mixture t:o pre'lent conversion of the generated angiotensin I to angiotensin

-l.l..
..
,,oc

'+

Briefly, the supernatant samples were allowed to thaw at
'

vortexed for 10 sec and 0. 025 ml aliquo ts

ferred to test tubes at 4°C.

~vere

trans-

Aliquots of 0.4 ml nephrecto-

rnized dog plasma (?H=7.56), previously treated with the
angiotensinase-and converting

enz~e

inhibitor ?henyl methyl

sulfonyl fluo::ide (PHSF:Sigma) and 2 drops of saturated NaCl,
\vere then added to.each test tube and vortexed.

T~e

resulting

mixture ~vas incubated for 2 hr at 37°C, diluted 3:1 ~vith acidified distilled water, vortexed, and then placed in a boiling
\vater bath fer 3 min to terminate the reaction.

The samples
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were then allo~ed to cool and then stored at -20°C until assayed for angiotensin I by radioimmunoassay.

The results

were expressed as nanograms of angiotensin I per

mg

of wet

tissue ?er hr.
Statistical analysis of the data was performed by modified Student's paired t-tests (202) using a programmable desk
top calculator (Hewlett-Packard) at Argonne National Laboratories (Argonne, Il.).

RESULTS

The effect of ?GE

(10

-5 M) and PGF -alpha (10 -5 M) on

2
2
renin release and cyclic AMP content in renal cortical slices
from sodium deficient rats, is

shot.;~n

in figure 1.

At the dose

used, both prostaglandins increased renin secretion by about 2
ng/mg/hr (in 5 out of 9 observations for PGE

2

and in 6 out of

10 cases for PGF 2-alpha) during a one-hr incubation period,
although the increase was not statistically significant. In
contrast, tissue cyclic AMP in res?onse to administration of
either PGE

2

or PGF ·alpha l:-7as markedly elevated
2

(p

0.01). in

relation to unstimulated, control samples (significant increases in 11 out of 12 instances for PGE

and in 10 out of

2

12 cases for PGF 1 -al?ha) .
....

Administration of the beta·adrenorecentor

b1oc~~er,

~'!"o-

not
1 t- -:. .,...
o .... ~ n .,.. .-==- 1 :. as c.
-·--·- ..,..
...............
- __ ._
....

.~

~~3

(,

1___
., ,;.·'

.. 0~ 1 0
-- ..t-~

~ '"'
:::> ,., ,.. ·~
......
s ,_~-------S

,.,.,..a
'"'O
increased by PG:" ?lus .,ro
.
;::-.... 1- o l-'· i::1. 11 out of

12·c~ses

~

tissue c-.\.:iF

~van

increased

.::ct "Jrevent t::e sti.::1ulato::·r
\-~

content ct-

t.. e
t ..

::e'1a.l.,

plus proprar:.olol)
of PGZ,.. alone on

~ffect

•
t~ssue

4i

:o.:;ure -? 1'

',:;'.
~-

•

t:~e

cyclic

3imilar res•.1lts
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(in 5 out of 10 cases renin release was increased by PGE
phentolaMine; in 11 out of 12 cases tissue

CA}~

plus
2
content by PGEz

plus phentolamine) were obtained when the alpha-adrenoreceptor
-I.

blocker, phentolamine (10 'M), :11as added to the renal cortical
?reparation

eit~er

alone or in conjunction with PGE? (Figure 3).

- content in

Changes in renin release and tissue cj·clic A}·fP
5

response to administration of 10- ~ PGF -alpha, either alone or
2
-4
-4
together ~vith 10 H propranolol or 10 M phentolamine, are
shown in figures 4 and 5, respectively. As seen previously
•
~·;it:!:l PGE , beta- or al;>ha-adrenergic receptor blockade ~-Jas
2
i~effective

in altering renin secretion (renin release

~as

in 6 out of 10 cases by PGF -alpha plus propranolol
2
and in 6 out of 10 cases of PGF 2 -alpha plus phentolamine) or
i~creased

in preventing the significant stimulatory effect of

?GF~-alpha
"-

on tissue cyclic

content.

~~~

(Tissue

creased in 11 out of 12 cases by

c-~-~

content was in-

PGF -alpha plus propran2
olol and PGF -alpha ?lus phentolamine.)
2
To evaluate the possibility t~at endogenous prostaglanbot~

dins participate in the regulation of resting (basal) renin
r:lease, the prostaglandin synthetase inhibitor,
(10

-4

:-:) ' was a dd e d

1

a~one

to

t he

1

• •

~~dney

cne-hr incubation ?eriod (Figure 5).

indomet~acin

s 1'~ce system

..J

•

~ur~ng

In the presence of

a

t~is
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agent, both renin release and tissue cyclic
mained unaltered
ples.
and
to

~-Jhen

.~~

content re-

compared to unstimulated control sam-

(Renin release was increased in 1 out of 5 instances

c-A}~

content inc=eased in 2 out of 6 cases in response

indomet~acin.)

!£feet of 10

-s M prostaglandin

-s

E (PGE 2 ) and 10
2
prostaglandin F2 -alpha (PGF -alpha) added separately, on
2
renin release and tissue cyclic ~~~ content in renal cortiFigure 1.

cal slices from sodium deficient rats.
the mean renin release change
A}~

content change

± SE.

± SE

The data represent

and the mean tissue cyclic

TI1e number of observations (n) and

the statistical significance of the observations are indicated.
was 6.39

The mean control (nontreated) rate of renin release

± 1.29

ng/mg/hr and the mean control tissue cyclic

A: IF content Nas 0. 34 + 0. 04 pmol/mg •.vet tissue.
time \vas 60 min.
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Figure 2.

Changes in renin release and tissue cyclic

M·~

con-

tent in response to 10 -"~ M prostaglandin E (PGE ) added alone
2
2
-4
or together r,.;ith 10
~1 propranolol (PRO) to renal cortical
slices from sodium deficient rats.
mean change in renin release
~~

content change

±

SE.

± SE

The data represent the
and the mean tissue cyclic

The number (n) of observations and

the statistical significance of the observations are indicated.

The mean control (nontreated) rate of renin release

added alone or together with ~0 was 6.30 ± 1.29
2
ng/m.g/hr and it: Nas 6.42 + 1.65 ng/mg/hr for PRO added alone.
for PGE

Corresponding values for tissue cyclic rll'I? content

± 0.04

and 0.39

± 0.08

pmol/mg

Incubation time \vas 60 min.
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tissue, respectively.
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Figure 3.

Changes in renin release and tissue cyclic ~~
-5
content in response to 10
M prostaglandin E2 (PGE ) added
2
-<+
alone or together with 10
~ phentolamine (PHEN) to renal
cortical slices from sodium deficient rats.

The data repre-

sent the mean change in renin release + SE and the mean tissue cyclic

content change

&~

± SE.

The number (n) of obser-

'lations and the statistical significance of the observations
~1e

are indicated.
relea.se for PGE

± 1.29

added alone or together with PEEN

ng/mg/hr and· it Nas 6.42

added alone.
tent

2

mean control (nontreated) rate of renin

~~Jere

.:t

Ai'~

0.08 pmol/mg wet tissue,

Incubation time was 60 min.
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Fi.::aure 4.

Changes in renin release and tissue cyclic AMP

content in response to 10

-5 !·f prostaglandin F -alpha (PGF 2
2

alpha) added alone or together

~vith

10

-4
M propranolol (PRO)

to renal cortical slices from sodium deficient rats.

The

data represent the mean change in renin release + SE and
the mean tissue cyclic

&~

content change

±

SE.

The num-

ber (n) of observations and the statistical significance
of the observations are indicated.

The mean control (non-

treated) rate of renin release for PGF -alpha ~dded alone
2
or together with PRO was 6.30 ± 1.29 ng/mg/hr and it was
6.42 + 1.65

ng/mg/~r

for PRO added alone.

Corresponding

values for tissue cyclic AMP content were 0.34 + 0.04 and
0.39

~

0.08 pmol/mg wet tissue, respectively.

time t;-7as 60 min.
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Figure 5.

Changes in renin release and tissue cyclic Al1P con-

tent in response to 10

-5

M prostaglandin F -alpha (PGF -alpha)
2
2
-4
added alone or together with 10 M phentolamine (PHEN) to
renal cortical slices from sodium deficient rats.

The data

represent the mean change in renin release + SE and the mean
tissue cyclic

A}~

content change

± SE.

The number (n) of ob-

servations and the statistical significance of the observations are indicated.

The mean control (nontreated) rate of

renin release for PGF -alpha added alone or together with
2
PHEN was 6.30 + 1.29 ng/mg/hr and 6.42 ± 1.65 ng/mg/hr for
PHEN added alone.
A~~

Corresponding values for tissue cyclic

content were 0.34 + 0.04- and 0.39 + 0.08 pmol/mg wet

tissue, respectively.

Incubation time was 60 min.
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Figure 6.

4
The effect of 10- M indomethacin (I) on resting

renin release and tissue cyclic A}W content in renal cortical slices from sodium deficient rats.

The data represent

the mean renin release + SE and the mean tissue cyclic AMP
content + SE of I-treated slice tissue (I) in relation to
unstimulated controls (c).
are indicated.

The number (n) of observations

Incubation time was 60 min.
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DISCUSSION
The in vitro renal cortical slice preparation has been
demonstrated to be a metabolically-viable system, as judged
by the linearity of renin release and tissue oxygen consump-

tion observed with time of incubation (1,3,203-207).

Utili-

zation of this type of preparation, which is devoid of hemodynamic, humoral and other factors knotvn to affect renin
secretion in the live animal, has allowed an effective eval•

uation of the direct effect of a number of isolated agents
on renin

releas.~

(1-4,87 ,96,98,101,117 ,208-211), including

those exerted by prostaglandins (9,10,13,14).
In the present study, the inability of both PGE

and
2
?GF -alpha to significantly stimulate renin release in vitro
2
is consistent with previous reports whic~ suggest that administration of these agents either does not affect renin release (11,12,15) or it only exerts a mild stimulatory effect

(10).

Alternatively, some studies (7,179,181,182) have pro-

vided data supporting the concept that PGE.,

.::.

~1as

the ability

to significantly stimulate renin release, whereas

oth~~rs

(9,13,14) have reported that PGF"-alpha significantly de"

?resses renin secretion.
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One possible explanation for the ccnflicting nature of
the data generated in these various studies, may be related
to the nature of the vehicle in which the prostaglandins are
routinely prepared.

wnorton et al. (10) have shown that

'Nhen ethanol is used as the solvent, concentrations of this
agent as low as

ul/5 ml of incubation medium diminish the

stiw1latory effect of PGE

1

on renin release by 33%, and

that administration of similarly-prepared PGF -alpha actual2
ly inhibits renin secretion. Conversely, the same investigators have shown that PGF -alpha significantly stimulates
2
renin release only when dissolved in albumin-containing
physiological buffer.

Although there are no corresponding

data pertaining to PGE , the fact that absolute ethanol was
2

utilized in the present study as the prostaglandin vehicle,
may partially account for the inability of both PGE

2

PGF -alpha to significantly influence renin release.
2

and
A

likely tvay by rl'1hich ethanol may participate in the prevention of the stimulatory effect of these prostaglandins on
renin secretion may be through its tvell-knmvn dehydrating
properties, tvhich tvould impair the metabolic viability of
the renal cortical cells.

Hmvever, our observation that

the cyclic AHP content of our renal cortical tissue tvas significantly increased, rather than decreased, by the addition
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of PGE

and PGF -alpha in this study makes a detrimental effect
2
2
of ethanol a less likely possibility.
To our knowledge, renin release and tissue cyclic

A.~

content responses to prostaglandin administration have not been
simultaneously evaluated in previous studies.
significant increases in tissue cyclic

A}~

The consistently

content caused by

both PGE 2 and PGF -alpha in this study, agree with previous
2
observations showing a marked stimulation of renal adenylate
cyclase systems by these agents (187-188).

lfuether or not the

increase in cyclic AMP seen in those studies was coupled with
corresponding changes in renin release can not be determined,
since the ttvo parameters

~vere

not measured simultaneously.

Clearly, however, our data indicate that at least at the dose
used in this study for both prostaglandins, their effects on
renin release and tissue cyclic A}W content were independent
of each other.
caused by PGE

The different effects on these two parameters

and PGF -alpha administration, contrast with
2
data related to the stimulatory effect exerted by catechola2

mines on renin secretion.

In these studies (1-4,35,36),

norepinep:1rine and dopamine significantly stimulated 'oot'::
renin release and tissue cyclic
cortic~l

tissu2,

sug~estin3

t.:at

Al~
t~~

content in rat renal
re~al

~eceptor

~echanism
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inv·: b;ed L"'l ':hese stLnulato:;:y resoonses utilizes cyclic
a mediator.

~-\:IP

as

.?urthermore, the same in"7estigators have shmvn

that the stimulatory effect of these catecholamines on both
?arameters, was effectively blocked by

t~e

beta-adrenoreceptor

antagonist, ;;)ropranolol, suggesting that the type of receptor
mechanism mediating these responses is of the beta- type.
Thus, the marked stimulatory effect of PGE

and PGF -alpha on
2
2
tissue cyclic AMP content seen in the present study, may re-

flect a selective, rather than generalized, stimulation of
renal-adenylate cyclase complexes different from those located
on the membrane of the JG cells.

The observation that propran-

olol administration did not alter the stimulatory effect
caused by both prostaglandins on tissue cyclic

Ai~

content,

is consistent with this view.
A number of studies (1,35,36,115,117,212) have also
shown that renal alpha-adrenergic receptor stimulation markedly depresses renin release and tissue cyclic &•W content, and
that this inhibitory effect on both parameters is effectively
converted to stimulation by administration of alpha-adrenoreceptor blocking agents.

The present results indicate that

alpha-adrenergic receptors do not participate in the action
of PGE
A~~

or PGF -alpha on either renin release or tissue cyclic
2
2
content, since alpha adrenoreceptor blockade by p~entolamine
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did not alter the changes seen in both parameters in response
to administration of either prostaglandin.

Thus, it appears

that neither beta-adrenergic nor alpha-adrenergic receptor
mechanisms, mediate the stimulatory effect of PGE

2

on the renal cyclic AMP content seen in this study.

and PGF 2
Also,

it is clear that at the dose used in this investigation,
neither prostaglandin was capable of significantly altering
resting renin release.

However, before a definite conclu-

sion regarding the possibility that prostaglandins may influence renin release can be reached, additional doses of
these agents must be examine, and alternative prostaglandins
such as prostacyclin (PGI ) must be evaluated alone and in
2
conjunction ~vith blocking agents. Furthermore, immunohistoc:.lemical studies designed to isolate e1e actual site of PGstimulated cyclic

N,~

content would be of great value in this

regard.
In vitro studies utilizing renal cortical tissue of rabbits (13,14) have shown that indomethacin, a knmvn prostaglandin synthetase inhibitor, significantly suppresses resting
renin release, an observation which suggests that engcdenous
renal prostaglandins participate in the minute-to-minute regulation of renin secretion in this species.

Similarly,

~omero
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et al. (25) have demonstrated in live dogs that indomethacin
is a potent inhibitor of resting renin release.

Using the

4
same concentration of indomethacin, (10- M), as these \vorkers,
ive observed a mean decrease in resting renin release after 60
min of incubation, although this decrease was not statistically significant.
rently support

Thus, the present in vitro data do not curt~e

concept that resting renin release is under

partial modulation by intrarenal prostaglandins.

Alternative-

ly, our results in the rat may be indicative of species differences or of differences in dietary sodium intake, since
previous studies employed animals maintained on commercial,
sodium replate diets.

The inability of indomethacin to in-

fluence resting renin release in this study,
in regard to the cyclic
sue.

A~W

~vas

also apparent

content of the renal cortical tis-

This observation further supports our view that in vitro

renin secretion in

t~e

rat is not regulated to any significant

extent by endogenous renal prostaglandins, since their activity should have been reflected in an increased adenylate cyclase stiwulation mimicking that observed in this study upon
administration of exogenous PGE

and PGF -alpha. It is clear
2
2
that further studies, designed to determine \vhether or nor the

marked stimulatory effect exerted by these prostaglandins on
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renal adenylate cyclase complexes can be altered by simultaneous indomethacin administration, are required before these
questions can be effectively answered.
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